Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 214 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Liakopoulos, Vassilios [Clear All Filters]
Albuminuria and cardiorenal risk..
Curr Opin Cardiol.
(2023).
(2023). Association of Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio with Calcification and Cardiovascular Markers in Chronic Kidney Disease..
Metabolites. 13(2),
(2023). Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?.
Eur J Clin Invest. 53(2), e13864.
(2023). Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis..
Nephrol Dial Transplant. 38(1), 203-211.
(2023). Effects of Home-Based Exercise Training on Cardiac Autonomic Neuropathy and Metabolic Profile in Diabetic Hemodialysis Patients..
Life (Basel). 13(1),
(2023). Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage..
J Pers Med. 13(3),
(2023). Frailty, sarcopenia and diabetic kidney disease: where do we stand?.
Int Urol Nephrol. 55(5), 1173-1181.
(2023). Kidney health for all: preparedness for the unexpected in supporting the vulnerable..
Kidney Int. 103(3), 436-443.
(2023). Measures of frequency and effect in clinical research..
Int Urol Nephrol.
(2023). N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties..
Int Urol Nephrol. 55(6), 1481-1492.
(2023). Redox Systems Biology in Chronic Kidney Disease..
Oxid Med Cell Longev. 2023, 9864037.
(2023). Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?.
Expert Opin Pharmacother.
(2023). Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023). Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023). Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells..
Int J Mol Sci. 23(24),
(2022). The effect of a 6-month intradialytic exercise program on hemodialysis adequacy and body composition: a randomized controlled trial..
Int Urol Nephrol. 54(11), 2983-2993.
(2022). Effects of a Combined Intradialytic Exercise Training Program and Music on Cardiac Autonomic Nervous System Activity in Hemodialysis Patients..
Life (Basel). 12(8),
(2022). Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population..
J Pers Med. 12(7),
(2022). Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells..
J Basic Clin Physiol Pharmacol.
(2022). Inhibition of Malate Dehydrogenase-2 Protects Renal Tubular Epithelial Cells from Anoxia-Reoxygenation-Induced Death or Senescence..
Biomolecules. 12(10),
(2022). The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria..
J Hypertens. 40(7), 1432-1433.
(2022). Kidney health for all: Bridging the gap in kidney health education and literacy..
J Ren Care. 48(2), 76-83.
(2022). Kidney health for all: bridging the gap in kidney health education and literacy..
J Nephrol. 35(6), 1555-1563.
(2022).